Elutia CFO’s Tight‑Bun Trade: Buying at 1.15, Selling at 1.09 Signals Confidence in FDA‑Clearance Catalyst — Net Gain of 477,190 Shares
Elutia CFO’s recent buy‑sell pattern shows confidence in the company’s FDA‑clearance and divestiture gains, offering investors a disciplined insider insight into potential upside.
4 minutes to read